SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-20-000967
Filing Date
2020-03-26
Accepted
2020-03-26 17:12:14
Documents
82
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K xenetic_10k-123119.htm 10-K 1156515
2 DESCRIPTION OF REGISTRANTS SECURITIES REGISTERED xenetic_10k-ex0401.htm EX-4.1 23672
3 LETTER AGREEMENT xenetic_10k-ex1050.htm EX-10.50 36925
4 FORM OF LETTER AGREEMENT xenetic_10k-ex1051.htm EX-10.51 40912
5 STOCK OPTION GRANT NOTICE xenetic_10k-ex1052.htm EX-10.52 73167
6 STOCK OPTION GRANT NOTICE xenetic_10k-ex1053.htm EX-10.53 75953
7 SUBSIDIARIES OF REGISTRANT xenetic_10k-ex2101.htm EX-21.1 2999
8 INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM S CONSENT xenetic_10k-ex2301.htm EX-23.1 2058
9 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER xenetic_10k-ex3101.htm EX-31.1 10150
10 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER xenetic_10k-ex3102.htm EX-31.2 10893
11 CERTIFICATION xenetic_10k-ex3201.htm EX-32.1 4785
12 GRAPHIC logo.jpg GRAPHIC 4625
  Complete submission text file 0001683168-20-000967.txt   5100709

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE xbio-20191231.xml EX-101.INS 702600
14 XBRL SCHEMA FILE xbio-20191231.xsd EX-101.SCH 45527
15 XBRL CALCULATION FILE xbio-20191231_cal.xml EX-101.CAL 55963
16 XBRL DEFINITION FILE xbio-20191231_def.xml EX-101.DEF 274819
17 XBRL LABEL FILE xbio-20191231_lab.xml EX-101.LAB 357383
18 XBRL PRESENTATION FILE xbio-20191231_pre.xml EX-101.PRE 345523
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37937 | Film No.: 20746920
SIC: 2834 Pharmaceutical Preparations